Type 2 di­a­betes drugs and weight loss: Cal­i­brate's mod­el starts with phar­ma and builds out

Cal­i­brate is look­ing to up­end the weight loss in­dus­try. And thanks to the drug in­dus­try, it’s got a se­cret weapon – GLP-1 meds.

Over the past few years, next-gen­er­a­tion Type 2 di­a­betes treat­ments have of­ten chat­ted up the weight-loss side ben­e­fit in TV com­mer­cials. Ac­tors and pa­tients in ads have of­ten said things like, “And I may even lose a lit­tle weight,” across cam­paigns for the glucagon-like pep­tide-1 brands such as Eli Lil­ly’s Trulic­i­ty and No­vo Nordisk’s Vic­toza, Ozem­pic and Ry­bel­sus.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER